XML 14 R5.htm IDEA: XBRL DOCUMENT v3.21.4
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Treasury Stock
Accumulated Other Comprehensive Income
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Balance at beginning of period, (in shares) at Oct. 02, 2020     66,921            
Balance at beginning of period at Oct. 02, 2020 $ 300,146   $ 67 $ (330) $ 5,009 $ 1,135,127   $ (839,727)  
Balance at beginning of period, treasury stock (in shares) at Oct. 02, 2020       23          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock option exercises (in shares)     10            
Stock option exercises 175         175      
Vesting of restricted common stock and units (in shares)     782            
Vesting of restricted common stock and units 0   $ 0            
Issuance of common stock pursuant to employee stock purchase plan (in shares)     93            
Issuance of common stock pursuant to employee stock purchase plan 2,239         2,239      
Shares repurchased for stock withholdings on restricted stock awards (in shares)     (297)            
Shares repurchased for tax withholdings on equity awards (11,844)         (11,844)      
Share-based compensation 10,131         10,131      
Other comprehensive loss, net of tax $ 1,129       1,129        
Accounting Standards Update [Extensible List] Accounting Standards Update 2020-06 [Member]                
Issuance of common stock for the cashless exercise of warrants (in shares)     858            
Issuance of common stock for the cashless exercise of warrants $ 36,442   $ 1     36,441      
Net income (8,968)             (8,968)  
Balance at end of period, (in shares) at Jan. 01, 2021     68,367            
Balance at end of period at Jan. 01, 2021 329,450   $ 68 $ (330) 6,138 1,172,269   (848,695)  
Balance at end of period, treasury stock (in shares) at Jan. 01, 2021       23          
Balance at beginning of period, (in shares) at Oct. 01, 2021     68,877            
Balance at beginning of period at Oct. 01, 2021 $ 471,736 $ (72,177) $ 69 $ (330) 4,150 1,269,601 $ (79,690) (801,754) $ 7,513
Balance at beginning of period, treasury stock (in shares) at Oct. 01, 2021       23          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock option exercises (in shares) 190   190            
Stock option exercises $ 2,688         2,688      
Vesting of restricted common stock and units (in shares)     969            
Vesting of restricted common stock and units 1   $ 1            
Issuance of common stock pursuant to employee stock purchase plan (in shares)     56            
Issuance of common stock pursuant to employee stock purchase plan 2,447         2,447      
Shares repurchased for stock withholdings on restricted stock awards (in shares)     (383)            
Shares repurchased for tax withholdings on equity awards (27,756)         (27,756)      
Share-based compensation 9,949         9,949      
Other comprehensive loss, net of tax (941)       (941)        
Net income 138,827             138,827  
Balance at end of period, (in shares) at Dec. 31, 2021     69,709            
Balance at end of period at Dec. 31, 2021 $ 524,774   $ 70 $ (330) $ 3,209 $ 1,177,239   $ (655,414)  
Balance at end of period, treasury stock (in shares) at Dec. 31, 2021       23